Resultados de la búsqueda 21-30 of 10702 for monoclonal antibody

  1. Hematología - Ensayos clínicos - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now. Rochester ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  10. Hematología - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...